The disaccharide trehalose inhibits proinflammatory phenotype activation in macrophages and prevents mortality in

Letteria Minutoli1, Domenica Altavilla, Alessandra Bitto

  • 1Departments of Clinical and Experimental Medicine and Pharmacology, University of Messina, Messina, Italy.

Shock (Augusta, Ga.)
|December 19, 2006
PubMed

Insights

Trehalose effectively inhibits the activation of macrophages

Area of Science:

  • Immunology
  • Cell Biology
  • Biochemistry

Background:

  • Sepsis-induced macrophage activation drives multiple organ dysfunction.
  • Trehalose is known to preserve cell viability under stress.

Purpose of the Study:

  • To investigate trehalose's potential to inhibit endotoxin-induced inflammatory activation in macrophages.
  • To evaluate trehalose's efficacy in preventing sepsis-related mortality in vivo.

Main Methods:

  • Primary rat macrophages were stimulated with lipopolysaccharide (LPS).
  • Cells were treated with varying concentrations of trehalose or sucrose.
  • Assessed inflammatory markers via Western blot, RT-PCR, and cytokine/nitrite measurements.
  • In vivo studies involved challenging rats with a lethal LPS dose and administering trehalose.

Main Results:

  • Trehalose significantly reduced LPS-induced activation of key inflammatory pathways (ERK, JNK, iNOS) in macrophages.
  • Trehalose suppressed the gene expression of pro-inflammatory cytokines (IL-1β, IL-6, TNF-α).
  • In vivo, trehalose administration increased survival rates in rats challenged with lethal LPS and reduced serum TNF-α levels.

Conclusions:

  • Trehalose demonstrates potent anti-inflammatory effects by inhibiting macrophage activation.
  • Trehalose offers significant protection against endotoxin-induced mortality in a sepsis model.
  • Sucrose did not exhibit similar protective effects, highlighting trehalose's specific mechanism.

Related Concept Videos